Actions of pirenzepine-dihydrochloride (LS-519 Cl) on gastric juice secretion, gastric motility and experimental gastric ulcer.
D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001570:Benzodiazepinones / Q000494:pharmacology*; D002217:Carbachol / Q000494:pharmacology; D004347:Drug Interactions; D004558:Electric Stimulation; D005750:Gastric Juice / Q000378:metabolism*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D008297:Male; D008460:Meat; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D013276:Stomach Ulcer / Q000188:drug therapy*; D013758:Tetragastrin / Q000494:pharmacology; D013997:Time Factors; D014020:Tissue Extracts; D014630:Vagus Nerve / Q000502:physiology
D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D010879:Piperazines; D014020:Tissue Extracts; D013758:Tetragastrin; D002217:Carbachol